Latest period
$5.33B
YoY change
+90.7%
5Y CAGR
+20.9%
Peak year (2025)
$16.81B
Latest annual
$16.81B
Operating Cash Flow history chart for Eli Lilly (LLY) from 1989 to 2025
Latest: $16.81B
Operating Cash Flow growth chart for Eli Lilly (LLY) from 1989 to 2025
Latest: +90.7%
Operating Cash Flow history table for Eli Lilly (LLY) from 1989 to 2025
| 2025 | $16.81B | +90.7% | +$8.00B | ||
| 2024 | $8.82B | +108.0% | +$4.58B | ||
| 2023 | $4.24B | -44.1% | −$3.35B | ||
| 2022 | $7.59B | +3.0% | +$219.80M | ||
| 2021 | $7.37B | +13.3% | +$866.30M | ||
| 2020 | $6.50B | +34.4% | +$1.66B | ||
| 2019 | $4.84B | -12.5% | −$687.90M | ||
| 2018 | $5.52B | -1.6% | −$91.10M | ||
| 2017 | $5.62B | +15.8% | +$764.60M | ||
| 2016 | $4.85B | +63.6% | +$1.89B | ||
| 2015 | $2.96B | -33.5% | −$1.49B | ||
| 2014 | $4.46B | -22.3% | −$1.28B | ||
| 2013 | $5.74B | +8.1% | +$430.20M | ||
| 2012 | $5.30B | -26.7% | −$1.93B | ||
| 2011 | $7.23B | +5.5% | +$377.70M | ||
| 2010 | $6.86B | +58.2% | +$2.52B | ||
| 2009 | $4.34B | -40.6% | −$2.96B | ||
| 2008 | $7.30B | +41.5% | +$2.14B | ||
| 2007 | $5.15B | +29.6% | +$1.18B | ||
| 2006 | $3.98B | +107.8% | +$2.06B | ||
| 2005 | $1.91B | -33.3% | −$955.90M | ||
| 2004 | $2.87B | -21.3% | −$777.20M | ||
| 2003 | $3.65B | +76.1% | +$1.58B | ||
| 2002 | $2.07B | -43.4% | −$1.59B | ||
| 2001 | $3.66B | -1.9% | −$69.90M | ||
| 2000 | $3.73B | +42.4% | +$1.11B | ||
| 1999 | $2.62B | -0.4% | −$10.10M | ||
| 1998 | $2.63B | +9.6% | +$229.40M | ||
| 1997 | $2.40B | +20.5% | +$409.00M | ||
| 1996 | $1.99B | +9.1% | +$166.80M | ||
| 1995 | $1.82B | +19.1% | +$292.30M | ||
| 1994 | $1.53B | +1.0% | +$15.40M | ||
| 1993 | $1.52B | +2.3% | +$33.40M | ||
| 1992 | $1.48B | +18.2% | +$228.90M | ||
| 1991 | $1.25B | -14.9% | −$219.80M | ||
| 1990 | $1.47B | +42.8% | +$441.80M | ||
| 1989 | $1.03B | — | — |
- 2025$16.81B+90.7%
- 2024$8.82B+108.0%
- 2023$4.24B-44.1%
- 2022$7.59B+3.0%
- 2021$7.37B+13.3%
- 2020$6.50B+34.4%
- 2019$4.84B-12.5%
- 2018$5.52B-1.6%
- 2017$5.62B+15.8%
- 2016$4.85B+63.6%
- 2015$2.96B-33.5%
- 2014$4.46B-22.3%
- 2013$5.74B+8.1%
- 2012$5.30B-26.7%
- 2011$7.23B+5.5%
- 2010$6.86B+58.2%
- 2009$4.34B-40.6%
- 2008$7.30B+41.5%
- 2007$5.15B+29.6%
- 2006$3.98B+107.8%
- 2005$1.91B-33.3%
- 2004$2.87B-21.3%
- 2003$3.65B+76.1%
- 2002$2.07B-43.4%
- 2001$3.66B-1.9%
- 2000$3.73B+42.4%
- 1999$2.62B-0.4%
- 1998$2.63B+9.6%
- 1997$2.40B+20.5%
- 1996$1.99B+9.1%
- 1995$1.82B+19.1%
- 1994$1.53B+1.0%
- 1993$1.52B+2.3%
- 1992$1.48B+18.2%
- 1991$1.25B-14.9%
- 1990$1.47B+42.8%
- 1989$1.03B—
Operating Cash Flow values are taken from Eli Lilly's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at Eli Lilly (LLY)
Operating Cash Flow for Eli Lilly (LLY): headline value $5.33B · YoY +90.7%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Eli Lilly (LLY) reported operating cash flow of $16.81B – surged 90.7% year-over-year.
Eli Lilly operating cash flow has grown for 2 consecutive years, with a +20.9% compound annual growth rate over 2020–2025 (5 years).
2025 marks the peak operating cash flow at $16.81B, with the historical low of $1.03B recorded in 1989.
Eli Lilly Operating Cash Flow by Year
Eli Lilly Operating Cash Flow 2025: $16.81B
2025's operating cash flow for Eli Lilly came in at $16.81B, surged 90.7% from 2024. This figure represents the highest annual value in the available history.
Eli Lilly Operating Cash Flow 2024: $8.82B
Eli Lilly posted operating cash flow of $8.82B in 2024, surged 108.0% from 2023.
Eli Lilly Operating Cash Flow 2023: $4.24B
In 2023, Eli Lilly reported operating cash flow of $4.24B, plunged 44.1% below 2022.
Eli Lilly Operating Cash Flow 2022: $7.59B
Eli Lilly operating cash flow in 2022 was $7.59B, edged up 3.0% from 2021.
Eli Lilly Operating Cash Flow 2021: $7.37B
Eli Lilly operating cash flow in 2021 was $7.37B.
See more financial history for Eli Lilly (LLY).
Sector peers by Operating Cash Flow
Healthcare peers of Eli Lilly (LLY), ranked by their latest operating cash flow
| $24.53B | |
| $19.70B | |
| $19.03B | |
| $18.56B | |
| $16.47B | |
| $14.57B | |
| $9.96B | |
| $7.82B |
- $24.53B
- $19.70B
- $19.03B
- $18.56B
- $16.47B
- $14.57B
- $9.96B
Frequently asked questions
Eli Lilly (LLY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation